APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biological Evaluation Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biological Evaluation Services Market Analysis and Forecast 2026-2032

Report ID 174079040216 April 2026247 pages

Choose your research edition.

Industry ResearchBiological Evaluation Services Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Biological Evaluation Services Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Biological Evaluation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biological Evaluation Services Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Biological Evaluation Services Market Analysis and Forecast 2026-2032247 pages · $4,950 USD

Market perspective

The global Biological Evaluation Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biological Evaluation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biological Evaluation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biological Evaluation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biological Evaluation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biological Evaluation Services include Charles River Laboratories, Labcorp, Namsa, SGS SA, TVU SUD, SenzaGen, LFH Regulatory, Med Institute and SCC Medical Devices, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biological Evaluation Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biological Evaluation Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Biological Evaluation Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biological Evaluation Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biological Evaluation Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biological Evaluation Services revenue, projected growth trends, production technology, application and end-user industry.

Biological Evaluation Services Segment by Company

Charles River Laboratories

Labcorp

Namsa

SGS SA

TVU SUD

SenzaGen

LFH Regulatory

Med Institute

SCC Medical Devices

Measurlabs

Sushvin

GBA Key2Compliance

Qserve

Thinqbetter

Groenakker

JordiLabs, LLC

Biotox Laboratories

Gnovo

Yimeida Meoical Device Consulting

Prima Drug Research Center

Mid Link

WuXi AppTec Medical Device Testing Center

Biological Evaluation Services Segment by Type

Toxicology Evaluation

Safety Pharmacology

Immunology Evaluation

Others

Biological Evaluation Services Segment by Application

Drugs

Medical Devices

Diagnostic Reagents

Biomaterials

Others

Biological Evaluation Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Evaluation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biological Evaluation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Evaluation Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biological Evaluation Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biological Evaluation Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biological Evaluation Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biological Evaluation Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Toxicology Evaluation Major Player Table 3. Safety Pharmacology Major Player Table 4. Immunology Evaluation Major Player Table 5. Others Major Player Table 6. Global Biological Evaluation Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Drugs Major Player Table 8. Medical Devices Major Player Table 9. Diagnostic Reagents Major Player Table 10. Biomaterials Major Player Table 11. Others Major Player Table 12. Biological Evaluation Services Industry Trends Table 13. Biological Evaluation Services Industry Drivers Table 14. Biological Evaluation Services Industry Opportunities and Challenges Table 15. Biological Evaluation Services Industry Restraints Table 16. Global Biological Evaluation Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Biological Evaluation Services Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Biological Evaluation Services Market Share by Region (2021-2026) Table 19. Global Biological Evaluation Services Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Biological Evaluation Services Market Share by Region (2027-2032) Table 21. Global Biological Evaluation Services Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Biological Evaluation Services Revenue Market Share by Players (2021-2026) Table 23. Global Biological Evaluation Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Biological Evaluation Services Key Players Headquarters & Area Served Table 25. Global Biological Evaluation Services Players, Product Type & Application Table 26. Global Biological Evaluation Services Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Biological Evaluation Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Biological Evaluation Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biological Evaluation Services Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Biological Evaluation Services Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Biological Evaluation Services Revenue Market Share by Type (2021-2026) Table 33. Global Biological Evaluation Services Revenue Market Share by Type (2027-2032) Table 34. Global Biological Evaluation Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Biological Evaluation Services Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Biological Evaluation Services Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Biological Evaluation Services Revenue Market Share by Application (2021-2026) Table 38. Global Biological Evaluation Services Revenue Market Share by Application (2027-2032) Table 39. Charles River Laboratories Company Information Table 40. Charles River Laboratories Business Overview Table 41. Charles River Laboratories Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Charles River Laboratories Biological Evaluation Services Product Portfolio Table 43. Charles River Laboratories Recent Development Table 44. Labcorp Company Information Table 45. Labcorp Business Overview Table 46. Labcorp Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Labcorp Biological Evaluation Services Product Portfolio Table 48. Labcorp Recent Development Table 49. Namsa Company Information Table 50. Namsa Business Overview Table 51. Namsa Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Namsa Biological Evaluation Services Product Portfolio Table 53. Namsa Recent Development Table 54. SGS SA Company Information Table 55. SGS SA Business Overview Table 56. SGS SA Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. SGS SA Biological Evaluation Services Product Portfolio Table 58. SGS SA Recent Development Table 59. TVU SUD Company Information Table 60. TVU SUD Business Overview Table 61. TVU SUD Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. TVU SUD Biological Evaluation Services Product Portfolio Table 63. TVU SUD Recent Development Table 64. SenzaGen Company Information Table 65. SenzaGen Business Overview Table 66. SenzaGen Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. SenzaGen Biological Evaluation Services Product Portfolio Table 68. SenzaGen Recent Development Table 69. LFH Regulatory Company Information Table 70. LFH Regulatory Business Overview Table 71. LFH Regulatory Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. LFH Regulatory Biological Evaluation Services Product Portfolio Table 73. LFH Regulatory Recent Development Table 74. Med Institute Company Information Table 75. Med Institute Business Overview Table 76. Med Institute Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Med Institute Biological Evaluation Services Product Portfolio Table 78. Med Institute Recent Development Table 79. SCC Medical Devices Company Information Table 80. SCC Medical Devices Business Overview Table 81. SCC Medical Devices Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. SCC Medical Devices Biological Evaluation Services Product Portfolio Table 83. SCC Medical Devices Recent Development Table 84. Measurlabs Company Information Table 85. Measurlabs Business Overview Table 86. Measurlabs Biological Evaluation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Measurlabs Biological Evaluation Services Product Portfolio Table 88. Measurlabs Recent Development Table 89. Sushvin Company Information Table 90. Sushvin Business Overview Table 91. Sushvin Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Sushvin Biological Evaluation Services Product Portfolio Table 93. Sushvin Recent Development Table 94. GBA Key2Compliance Company Information Table 95. GBA Key2Compliance Business Overview Table 96. GBA Key2Compliance Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. GBA Key2Compliance Biological Evaluation Services Product Portfolio Table 98. GBA Key2Compliance Recent Development Table 99. Qserve Company Information Table 100. Qserve Business Overview Table 101. Qserve Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Qserve Biological Evaluation Services Product Portfolio Table 103. Qserve Recent Development Table 104. Thinqbetter Company Information Table 105. Thinqbetter Business Overview Table 106. Thinqbetter Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Thinqbetter Biological Evaluation Services Product Portfolio Table 108. Thinqbetter Recent Development Table 109. Groenakker Company Information Table 110. Groenakker Business Overview Table 111. Groenakker Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Groenakker Biological Evaluation Services Product Portfolio Table 113. Groenakker Recent Development Table 114. JordiLabs, LLC Company Information Table 115. JordiLabs, LLC Business Overview Table 116. JordiLabs, LLC Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. JordiLabs, LLC Biological Evaluation Services Product Portfolio Table 118. JordiLabs, LLC Recent Development Table 119. Biotox Laboratories Company Information Table 120. Biotox Laboratories Business Overview Table 121. Biotox Laboratories Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Biotox Laboratories Biological Evaluation Services Product Portfolio Table 123. Biotox Laboratories Recent Development Table 124. Gnovo Company Information Table 125. Gnovo Business Overview Table 126. Gnovo Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Gnovo Biological Evaluation Services Product Portfolio Table 128. Gnovo Recent Development Table 129. Yimeida Meoical Device Consulting Company Information Table 130. Yimeida Meoical Device Consulting Business Overview Table 131. Yimeida Meoical Device Consulting Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Yimeida Meoical Device Consulting Biological Evaluation Services Product Portfolio Table 133. Yimeida Meoical Device Consulting Recent Development Table 134. Prima Drug Research Center Company Information Table 135. Prima Drug Research Center Business Overview Table 136. Prima Drug Research Center Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Prima Drug Research Center Biological Evaluation Services Product Portfolio Table 138. Prima Drug Research Center Recent Development Table 139. Mid Link Company Information Table 140. Mid Link Business Overview Table 141. Mid Link Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Mid Link Biological Evaluation Services Product Portfolio Table 143. Mid Link Recent Development Table 144. WuXi AppTec Medical Device Testing Center Company Information Table 145. WuXi AppTec Medical Device Testing Center Business Overview Table 146. WuXi AppTec Medical Device Testing Center Biological Evaluation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. WuXi AppTec Medical Device Testing Center Biological Evaluation Services Product Portfolio Table 148. WuXi AppTec Medical Device Testing Center Recent Development Table 149. North America Biological Evaluation Services Revenue by Type (2021-2026) & (US$ Million) Table 150. North America Biological Evaluation Services Revenue by Type (2027-2032) & (US$ Million) Table 151. North America Biological Evaluation Services Revenue by Application (2021-2026) & (US$ Million) Table 152. North America Biological Evaluation Services Revenue by Application (2027-2032) & (US$ Million) Table 153. North America Biological Evaluation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America Biological Evaluation Services Revenue by Country (2021-2026) & (US$ Million) Table 155. North America Biological Evaluation Services Revenue by Country (US$ Million) & (2027-2032) Table 156. Europe Biological Evaluation Services Revenue by Type (2021-2026) & (US$ Million) Table 157. Europe Biological Evaluation Services Revenue by Type (2027-2032) & (US$ Million) Table 158. Europe Biological Evaluation Services Revenue by Application (2021-2026) & (US$ Million) Table 159. Europe Biological Evaluation Services Revenue by Application (2027-2032) & (US$ Million) Table 160. Europe Biological Evaluation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe Biological Evaluation Services Revenue by Country (2021-2026) & (US$ Million) Table 162. Europe Biological Evaluation Services Revenue by Country (US$ Million) & (2027-2032) Table 163. China Biological Evaluation Services Revenue by Type (2021-2026) & (US$ Million) Table 164. China Biological Evaluation Services Revenue by Type (2027-2032) & (US$ Million) Table 165. China Biological Evaluation Services Revenue by Application (2021-2026) & (US$ Million) Table 166. China Biological Evaluation Services Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Biological Evaluation Services Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Biological Evaluation Services Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Biological Evaluation Services Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Biological Evaluation Services Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Biological Evaluation Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Biological Evaluation Services Revenue by Region (US$ Million) & (2021-2026) Table 173. Asia Biological Evaluation Services Revenue by Region (US$ Million) & (2027-2032) Table 174. SAMEA Biological Evaluation Services Revenue by Type (2021-2026) & (US$ Million) Table 175. SAMEA Biological Evaluation Services Revenue by Type (2027-2032) & (US$ Million) Table 176. SAMEA Biological Evaluation Services Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA Biological Evaluation Services Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA Biological Evaluation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. SAMEA Biological Evaluation Services Revenue by Country (2021-2026) & (US$ Million) Table 180. SAMEA Biological Evaluation Services Revenue by Country (US$ Million) & (2027-2032) Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Biological Evaluation Services Image Figure 2. Global Biological Evaluation Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biological Evaluation Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Toxicology Evaluation Image Figure 5. Safety Pharmacology Image Figure 6. Immunology Evaluation Image Figure 7. Others Image Figure 8. Global Biological Evaluation Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Biological Evaluation Services Market Size Share 2021 VS 2025 VS 2032 Figure 10. Drugs Image Figure 11. Medical Devices Image Figure 12. Diagnostic Reagents Image Figure 13. Biomaterials Image Figure 14. Others Image Figure 15. Global Biological Evaluation Services Market Size (US$ Million) & (2021-2032) Figure 16. Global Biological Evaluation Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Biological Evaluation Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Biological Evaluation Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Biological Evaluation Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Biological Evaluation Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Biological Evaluation Services Revenue Market Share by Type (2021-2032) Figure 23. Global Biological Evaluation Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Biological Evaluation Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Biological Evaluation Services Revenue Market Share by Application (2021-2032) Figure 26. North America Biological Evaluation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Biological Evaluation Services Revenue Share by Type (2021-2032) Figure 28. North America Biological Evaluation Services Revenue Share by Application (2021-2032) Figure 29. North America Biological Evaluation Services Revenue Share by Country (2021-2032) Figure 30. United States Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Biological Evaluation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Biological Evaluation Services Revenue Share by Type (2021-2032) Figure 35. Europe Biological Evaluation Services Revenue Share by Application (2021-2032) Figure 36. Europe Biological Evaluation Services Revenue Share by Country (2021-2032) Figure 37. Germany Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Biological Evaluation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Biological Evaluation Services Revenue Share by Type (2021-2032) Figure 47. China Biological Evaluation Services Revenue Share by Application (2021-2032) Figure 48. Asia Biological Evaluation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Biological Evaluation Services Revenue Share by Type (2021-2032) Figure 50. Asia Biological Evaluation Services Revenue Share by Application (2021-2032) Figure 51. Asia Biological Evaluation Services Revenue Share by Region (2021-2032) Figure 52. Japan Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Biological Evaluation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Biological Evaluation Services Revenue Share by Type (2021-2032) Figure 60. SAMEA Biological Evaluation Services Revenue Share by Application (2021-2032) Figure 61. SAMEA Biological Evaluation Services Revenue Share by Country (2021-2032) Figure 62. Brazil Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Biological Evaluation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Toxicology Evaluation
  • Safety Pharmacology
  • Immunology Evaluation
  • Others
Applications
  • Drugs
  • Medical Devices
  • Diagnostic Reagents
  • Biomaterials
  • Others
Companies covered
  • Charles River Laboratories
  • Labcorp
  • Namsa
  • SGS SA
  • TVU SUD
  • SenzaGen
  • LFH Regulatory
  • Med Institute
  • SCC Medical Devices
  • Measurlabs
  • Sushvin
  • GBA Key2Compliance
  • Qserve
  • Thinqbetter
  • Groenakker
  • JordiLabs, LLC
  • Biotox Laboratories
  • Gnovo
  • Yimeida Meoical Device Consulting
  • Prima Drug Research Center
  • Mid Link
  • WuXi AppTec Medical Device Testing Center

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biological Evaluation Services Market by Type
  3. 1.2.1 Global Biological Evaluation Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Toxicology Evaluation
  5. 1.2.3 Safety Pharmacology
  6. 1.2.4 Immunology Evaluation
  7. 1.2.5 Others
  8. 1.3 Biological Evaluation Services Market by Application
  9. 1.3.1 Global Biological Evaluation Services Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Drugs
  11. 1.3.3 Medical Devices
  12. 1.3.4 Diagnostic Reagents
  13. 1.3.5 Biomaterials
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Biological Evaluation Services Market Dynamics
  1. 2.1 Biological Evaluation Services Industry Trends
  2. 2.2 Biological Evaluation Services Industry Drivers
  3. 2.3 Biological Evaluation Services Industry Opportunities and Challenges
  4. 2.4 Biological Evaluation Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biological Evaluation Services Market Perspective (2021-2032)
  2. 3.2 Global Biological Evaluation Services Growth Trends by Region
  3. 3.2.1 Global Biological Evaluation Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biological Evaluation Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Biological Evaluation Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biological Evaluation Services Revenue by Players
  2. 4.1.1 Global Biological Evaluation Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Biological Evaluation Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biological Evaluation Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biological Evaluation Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biological Evaluation Services Key Players Headquarters & Area Served
  7. 4.4 Global Biological Evaluation Services Players, Product Type & Application
  8. 4.5 Global Biological Evaluation Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biological Evaluation Services Market CR5 and HHI
  11. 4.6.3 2025 Biological Evaluation Services Tier 1, Tier 2, and Tier 3
5 Biological Evaluation Services Market Size by Type
  1. 5.1 Global Biological Evaluation Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biological Evaluation Services Revenue by Type (2021-2032)
  3. 5.3 Global Biological Evaluation Services Revenue Market Share by Type (2021-2032)
6 Biological Evaluation Services Market Size by Application
  1. 6.1 Global Biological Evaluation Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biological Evaluation Services Revenue by Application (2021-2032)
  3. 6.3 Global Biological Evaluation Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Charles River Laboratories
  2. 7.1.1 Charles River Laboratories Company Information
  3. 7.1.2 Charles River Laboratories Business Overview
  4. 7.1.3 Charles River Laboratories Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Charles River Laboratories Biological Evaluation Services Product Portfolio
  6. 7.1.5 Charles River Laboratories Recent Developments
  7. 7.2 Labcorp
  8. 7.2.1 Labcorp Company Information
  9. 7.2.2 Labcorp Business Overview
  10. 7.2.3 Labcorp Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Labcorp Biological Evaluation Services Product Portfolio
  12. 7.2.5 Labcorp Recent Developments
  13. 7.3 Namsa
  14. 7.3.1 Namsa Company Information
  15. 7.3.2 Namsa Business Overview
  16. 7.3.3 Namsa Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Namsa Biological Evaluation Services Product Portfolio
  18. 7.3.5 Namsa Recent Developments
  19. 7.4 SGS SA
  20. 7.4.1 SGS SA Company Information
  21. 7.4.2 SGS SA Business Overview
  22. 7.4.3 SGS SA Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SGS SA Biological Evaluation Services Product Portfolio
  24. 7.4.5 SGS SA Recent Developments
  25. 7.5 TVU SUD
  26. 7.5.1 TVU SUD Company Information
  27. 7.5.2 TVU SUD Business Overview
  28. 7.5.3 TVU SUD Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 TVU SUD Biological Evaluation Services Product Portfolio
  30. 7.5.5 TVU SUD Recent Developments
  31. 7.6 SenzaGen
  32. 7.6.1 SenzaGen Company Information
  33. 7.6.2 SenzaGen Business Overview
  34. 7.6.3 SenzaGen Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 SenzaGen Biological Evaluation Services Product Portfolio
  36. 7.6.5 SenzaGen Recent Developments
  37. 7.7 LFH Regulatory
  38. 7.7.1 LFH Regulatory Company Information
  39. 7.7.2 LFH Regulatory Business Overview
  40. 7.7.3 LFH Regulatory Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 LFH Regulatory Biological Evaluation Services Product Portfolio
  42. 7.7.5 LFH Regulatory Recent Developments
  43. 7.8 Med Institute
  44. 7.8.1 Med Institute Company Information
  45. 7.8.2 Med Institute Business Overview
  46. 7.8.3 Med Institute Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Med Institute Biological Evaluation Services Product Portfolio
  48. 7.8.5 Med Institute Recent Developments
  49. 7.9 SCC Medical Devices
  50. 7.9.1 SCC Medical Devices Company Information
  51. 7.9.2 SCC Medical Devices Business Overview
  52. 7.9.3 SCC Medical Devices Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 SCC Medical Devices Biological Evaluation Services Product Portfolio
  54. 7.9.5 SCC Medical Devices Recent Developments
  55. 7.10 Measurlabs
  56. 7.10.1 Measurlabs Company Information
  57. 7.10.2 Measurlabs Business Overview
  58. 7.10.3 Measurlabs Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Measurlabs Biological Evaluation Services Product Portfolio
  60. 7.10.5 Measurlabs Recent Developments
  61. 7.11 Sushvin
  62. 7.11.1 Sushvin Company Information
  63. 7.11.2 Sushvin Business Overview
  64. 7.11.3 Sushvin Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sushvin Biological Evaluation Services Product Portfolio
  66. 7.11.5 Sushvin Recent Developments
  67. 7.12 GBA Key2Compliance
  68. 7.12.1 GBA Key2Compliance Company Information
  69. 7.12.2 GBA Key2Compliance Business Overview
  70. 7.12.3 GBA Key2Compliance Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 GBA Key2Compliance Biological Evaluation Services Product Portfolio
  72. 7.12.5 GBA Key2Compliance Recent Developments
  73. 7.13 Qserve
  74. 7.13.1 Qserve Company Information
  75. 7.13.2 Qserve Business Overview
  76. 7.13.3 Qserve Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Qserve Biological Evaluation Services Product Portfolio
  78. 7.13.5 Qserve Recent Developments
  79. 7.14 Thinqbetter
  80. 7.14.1 Thinqbetter Company Information
  81. 7.14.2 Thinqbetter Business Overview
  82. 7.14.3 Thinqbetter Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Thinqbetter Biological Evaluation Services Product Portfolio
  84. 7.14.5 Thinqbetter Recent Developments
  85. 7.15 Groenakker
  86. 7.15.1 Groenakker Company Information
  87. 7.15.2 Groenakker Business Overview
  88. 7.15.3 Groenakker Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Groenakker Biological Evaluation Services Product Portfolio
  90. 7.15.5 Groenakker Recent Developments
  91. 7.16 JordiLabs, LLC
  92. 7.16.1 JordiLabs, LLC Company Information
  93. 7.16.2 JordiLabs, LLC Business Overview
  94. 7.16.3 JordiLabs, LLC Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 JordiLabs, LLC Biological Evaluation Services Product Portfolio
  96. 7.16.5 JordiLabs, LLC Recent Developments
  97. 7.17 Biotox Laboratories
  98. 7.17.1 Biotox Laboratories Company Information
  99. 7.17.2 Biotox Laboratories Business Overview
  100. 7.17.3 Biotox Laboratories Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Biotox Laboratories Biological Evaluation Services Product Portfolio
  102. 7.17.5 Biotox Laboratories Recent Developments
  103. 7.18 Gnovo
  104. 7.18.1 Gnovo Company Information
  105. 7.18.2 Gnovo Business Overview
  106. 7.18.3 Gnovo Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Gnovo Biological Evaluation Services Product Portfolio
  108. 7.18.5 Gnovo Recent Developments
  109. 7.19 Yimeida Meoical Device Consulting
  110. 7.19.1 Yimeida Meoical Device Consulting Company Information
  111. 7.19.2 Yimeida Meoical Device Consulting Business Overview
  112. 7.19.3 Yimeida Meoical Device Consulting Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Yimeida Meoical Device Consulting Biological Evaluation Services Product Portfolio
  114. 7.19.5 Yimeida Meoical Device Consulting Recent Developments
  115. 7.20 Prima Drug Research Center
  116. 7.20.1 Prima Drug Research Center Company Information
  117. 7.20.2 Prima Drug Research Center Business Overview
  118. 7.20.3 Prima Drug Research Center Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Prima Drug Research Center Biological Evaluation Services Product Portfolio
  120. 7.20.5 Prima Drug Research Center Recent Developments
  121. 7.21 Mid Link
  122. 7.21.1 Mid Link Company Information
  123. 7.21.2 Mid Link Business Overview
  124. 7.21.3 Mid Link Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Mid Link Biological Evaluation Services Product Portfolio
  126. 7.21.5 Mid Link Recent Developments
  127. 7.22 WuXi AppTec Medical Device Testing Center
  128. 7.22.1 WuXi AppTec Medical Device Testing Center Company Information
  129. 7.22.2 WuXi AppTec Medical Device Testing Center Business Overview
  130. 7.22.3 WuXi AppTec Medical Device Testing Center Biological Evaluation Services Revenue and Gross Margin (2021-2026)
  131. 7.22.4 WuXi AppTec Medical Device Testing Center Biological Evaluation Services Product Portfolio
  132. 7.22.5 WuXi AppTec Medical Device Testing Center Recent Developments
8 North America
  1. 8.1 North America Biological Evaluation Services Revenue (2021-2032)
  2. 8.2 North America Biological Evaluation Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Biological Evaluation Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Biological Evaluation Services Revenue by Type (2027-2032)
  5. 8.3 North America Biological Evaluation Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Biological Evaluation Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Biological Evaluation Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Biological Evaluation Services Revenue by Application (2027-2032)
  9. 8.5 North America Biological Evaluation Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Biological Evaluation Services Revenue by Country
  11. 8.6.1 North America Biological Evaluation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biological Evaluation Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Biological Evaluation Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biological Evaluation Services Revenue (2021-2032)
  2. 9.2 Europe Biological Evaluation Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biological Evaluation Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biological Evaluation Services Revenue by Type (2027-2032)
  5. 9.3 Europe Biological Evaluation Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biological Evaluation Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biological Evaluation Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biological Evaluation Services Revenue by Application (2027-2032)
  9. 9.5 Europe Biological Evaluation Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biological Evaluation Services Revenue by Country
  11. 9.6.1 Europe Biological Evaluation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biological Evaluation Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biological Evaluation Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biological Evaluation Services Revenue (2021-2032)
  2. 10.2 China Biological Evaluation Services Revenue by Type (2021-2032)
  3. 10.2.1 China Biological Evaluation Services Revenue by Type (2021-2026)
  4. 10.2.2 China Biological Evaluation Services Revenue by Type (2027-2032)
  5. 10.3 China Biological Evaluation Services Revenue Share by Type (2021-2032)
  6. 10.4 China Biological Evaluation Services Revenue by Application (2021-2032)
  7. 10.4.1 China Biological Evaluation Services Revenue by Application (2021-2026)
  8. 10.4.2 China Biological Evaluation Services Revenue by Application (2027-2032)
  9. 10.5 China Biological Evaluation Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biological Evaluation Services Revenue (2021-2032)
  2. 11.2 Asia Biological Evaluation Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biological Evaluation Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biological Evaluation Services Revenue by Type (2027-2032)
  5. 11.3 Asia Biological Evaluation Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biological Evaluation Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biological Evaluation Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biological Evaluation Services Revenue by Application (2027-2032)
  9. 11.5 Asia Biological Evaluation Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biological Evaluation Services Revenue by Country
  11. 11.6.1 Asia Biological Evaluation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biological Evaluation Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biological Evaluation Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biological Evaluation Services Revenue (2021-2032)
  2. 12.2 SAMEA Biological Evaluation Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biological Evaluation Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biological Evaluation Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biological Evaluation Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biological Evaluation Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biological Evaluation Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biological Evaluation Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biological Evaluation Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biological Evaluation Services Revenue by Country
  11. 12.6.1 SAMEA Biological Evaluation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biological Evaluation Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biological Evaluation Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst